News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
FDA
Meet the Powerful Woman Behind the Scenes of Sarepta’s DMD Drug Approval
September 20, 2016
·
4 min read
FDA
Victory at Last! Sarepta Stock Doubles as the FDA Finally Approves DMD Drug
September 19, 2016
·
3 min read
Business
Turn the Page: Sarepta Stock Pops on Rumors DMD Drug Naysayer Leaves the FDA
September 14, 2016
·
3 min read
Biotech Beach
3 High-Risk, High-Reward Biotech Stocks
August 24, 2016
·
3 min read
Policy
Sarepta’s Duchene Muscular Dystrophy Drug: Evaluating the Placebo Effect
August 19, 2016
·
4 min read
Drug Development
Sarepta Stock Surges After Government Website Indicates Firm is Recruiting for Phase III Study
August 4, 2016
·
3 min read
Policy
Sarepta Surges Yet Again, as the FDA Requests More Data About Duchenne’s Drug
June 7, 2016
·
3 min read
Policy
All Eyes Turn to Sarepta as BioMarin Shutters Its Kyndrisa Duchenne Program
June 1, 2016
·
4 min read
Policy
Approving Sarepta’s DMD Drug Could Force FDA To Get Creative
May 26, 2016
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 30, 2020
November 30, 2020
·
2 min read
Genetown
Sarepta Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
November 25, 2020
·
1 min read
Genetown
Sarepta Therapeutics Named One of The Boston Globe’s Top Places to Work 2020
November 20, 2020
·
3 min read
Business
Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
November 5, 2020
·
35 min read
Genetown
Sarepta Therapeutics to Commence Dosing of the Next Study with Commercial Process Material for the SRP-9001 Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy
November 5, 2020
·
6 min read
Genetown
Sarepta Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
November 2, 2020
·
1 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 30, 2020
October 30, 2020
·
2 min read
Business
Sarepta Therapeutics to Announce Third Quarter 2020 Financial Results and Recent Corporate Developments on November 5, 2020
October 29, 2020
·
1 min read
Business
Gene Therapy Company AavantiBio Launches with $107 Million Series A Financing from Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics
October 22, 2020
·
10 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 30, 2020
September 30, 2020
·
2 min read
